Literature DB >> 1431589

Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids.

F Karpe1, T Olivecrona, G Walldius, A Hamsten.   

Abstract

Lipoprotein lipase (LPL) releases fatty acids from triglyceride-rich lipoproteins for use in cellular metabolic reactions. How this hydrolysis, which occurs at the vascular endothelium, is regulated is poorly understood. A fatty acid feedback system has been proposed by which accumulation of fatty acids impedes LPL-catalyzed hydrolysis and dissociates the enzyme from its endothelial binding sites. We examined this hypothesis in humans who were subjected to an oral fat tolerance test of a mixed-meal type. Plasma triglycerides, free fatty acids, and LPL activity were measured before and repeatedly during a 12-h period after intake of the fat load. Since soybean oil with a high content of linoleic fatty acid was the source of triglycerides, a distinction could be made between endogenous free fatty acids (FFA) and FFA derived directly from lipolysis of postprandial triglyceride-rich lipoproteins. Mean LPL activity was almost doubled (P less than 0.01) 6 h after intake of the oral fat load. The rise in LPL activity was accompanied by an increase of plasma triglycerides and linoleic free fatty acids (18:2 FFA), but not of total plasma FFA, which instead displayed a heterogeneous pattern with essentially unchanged mean levels. The postprandial response of LPL activity largely paralleled the postprandial responses of 18:2 FFA and triglycerides. The highest degree of parallelism was seen between postprandial 18:2 FFA and LPL activity levels. Furthermore, the integrated response (area under the curve, AUC) for plasma measurements of LPL correlated with the AUC for 18:2 FFA (r = 0.40, P less than 0.05), but not with the AUC for plasma triglycerides (r = 0.21, ns). The high degree of parallelism and significant correlation between postprandial plasma LPL activity and 18:2 FFA support the hypothesis of fatty acid control of endothelial LPL during physiological conditions in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431589

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

1.  The tissue distribution of lipoprotein lipase determines where chylomicrons bind.

Authors:  Roger Savonen; Michaela Hiden; Magnus Hultin; Rudolf Zechner; Sanja Levak-Frank; Gunilla Olivecrona; Thomas Olivecrona
Journal:  J Lipid Res       Date:  2015-01-14       Impact factor: 5.922

2.  Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs.

Authors:  Antoni Pastor; Magí Farré; Montserrat Fitó; Fernando Fernandez-Aranda; Rafael de la Torre
Journal:  J Lipid Res       Date:  2014-03-07       Impact factor: 5.922

3.  Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry.

Authors:  Mart Reimund; Oleg Kovrov; Gunilla Olivecrona; Aivar Lookene
Journal:  J Lipid Res       Date:  2016-11-14       Impact factor: 5.922

4.  Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.

Authors:  Gunilla Olivecrona; Ewa Ehrenborg; Henrik Semb; Elena Makoveichuk; Anna Lindberg; Michael R Hayden; Peter Gin; Brandon S J Davies; Michael M Weinstein; Loren G Fong; Anne P Beigneux; Stephen G Young; Thomas Olivecrona; Olle Hernell
Journal:  J Lipid Res       Date:  2009-12-21       Impact factor: 5.922

5.  Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion.

Authors:  Y Park; B D Damron; J M Miles; W S Harris
Journal:  Lipids       Date:  2001-02       Impact factor: 1.880

6.  Effects of acute lipid overload on skeletal muscle insulin resistance, metabolic flexibility, and mitochondrial performance.

Authors:  John J Dubé; Paul M Coen; Giovanna DiStefano; Alexander C Chacon; Nicole L Helbling; Marisa E Desimone; Maja Stafanovic-Racic; Kazanna C Hames; Alex A Despines; Frederico G S Toledo; Bret H Goodpaster
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-28       Impact factor: 4.310

7.  Postprandial interleukin-6 response in elderly with abdominal obesity and metabolic syndrome.

Authors:  P F P Moreira; M A Dalboni; M Cendoroglo; G M S Santos; M S Cendoroglo
Journal:  J Nutr Health Aging       Date:  2013-03       Impact factor: 4.075

8.  Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.

Authors:  M Castro Cabezas; T W de Bruin; H W de Valk; C C Shoulders; H Jansen; D Willem Erkelens
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients.

Authors:  C Saloranta; L Groop; A Ekstrand; A Franssila-Kallunki; M R Taskinen
Journal:  Acta Diabetol       Date:  1994-04       Impact factor: 4.280

10.  Binding of lipoprotein lipase to alpha 2-macroglobulin.

Authors:  E Vilella; G Bengtsson-Olivecrona; T Stigbrand; P E Jensen
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.